Onconase FDA Approval Status
FDA Approved: No
Brand name: Onconase
Generic name: ranpirnase
Company: Alfacell Corporation
Treatment for: Malignant Pleural Mesothelioma
Onconase (ranpirnase) is a ribonuclease enzyme in development for the treatment of unresectable malignant mesothelioma.
Development timeline for Onconase
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
